Moehler, M; Mueller, A; Trarbach, T et al.
Cetuximab with irinotecan, folinic acid and 5-fluorouracil as first-line treatment in advanced gastroesophageal cancer: a prospective multi-center biomarker-oriented phase II studyANNALS OF ONCOLOGY. Bd. 22. H. 6. 2011 S. 1358-1366
Kukolj, G; Legace, L; Cartier, M et al.
CHARACTERIZATION OF HCV NS3 VARIANTS THAT EMERGED DURING VIROLOGIC BREAKTHROUGH AND RELAPSE FROM BI201335 PHASE 2 SILEN-C1 STUDYHEPATOLOGY. Bd. 54. 2011 S. 991A-991A
Neurath, MF
CHRONIC INFLAMMATORY BOWEL DISEASE - FROM BENCH TO BEDSIDECLINICAL CHEMISTRY AND LABORATORY MEDICINE. Bd. 49. 2011 S. S10-S10
Luth, S; Schrader, J; Zander, S et al.
Chronic Inflammatory IFN-gamma Signaling Suppresses Hepatocarcinogenesis in Mice by Sensitizing Hepatocytes for ApoptosisCANCER RESEARCH. Bd. 71. H. 11. 2011 S. 3763-3771
Kornek, M; Lynch, M; Exley, M et al.
CIRCULATING HUMAN INFLAMMATORY CELL MICROPARTICLES (MP): A NOVEL TOOL TO ASSESS SEVERITY OF HEPATIC INFLAMMATION IN HEPATITIS C AND NASHJOURNAL OF HEPATOLOGY. Bd. 54. 2011 S. S43-S44
Kornek, M; Lynch, M; Exley, MA et al.
CIRCULATING MACROPHAGE/MONOCYTE (CD14+) MICROPARTICLES ARE A HALLMARK OF METABOLIC INFLAMMATION IN NASHHEPATOLOGY. Bd. 54. 2011 S. 368A-368A
Bitzer, M; Horger, M; Ganten, T et al.
CLINICAL UPDATE ON THE PHASE I/II TRIAL OF HDAC INHIBITOR RESMINOSTAT IN PATIENTS WITH SORAFENIB-RESISTANT HEPATOCELLULAR CARCINOMA (HCC) - THE SHELTER STUDYANNALS OF ONCOLOGY. Bd. 22. 2011 S. v76-v76
Kroeger, I; Meinhardt, K; Abendroth, A et al.
Clinical, endoscopic and molecular characterization of murine GvHD colitisBONE MARROW TRANSPLANTATION. Bd. 46. 2011 S. S243-S243
Goetz, M
Colonoscopic Surveillance in Inflammatory Bowel Disease: State of the Art Reduction of BiopsiesDIGESTIVE DISEASES. Bd. 29. 2011 S. 36-40
Goetz, M; Kiesslich, R
Colorectal Carcinoma - What is the Benefit of Novel Techniques such as Chromoendoscopy and Endomicroscopy?ENDOSKOPIE HEUTE. Bd. 24. H. 3. 2011 S. 160-163